Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Leone

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancer Immunology Research|March 2, 2021
Fueling the Revolution: Targeting Metabolism to Enhance ImmunotherapyRobert D Leone, Jonathan D Powell
Trends in Endocrinology and Metabolism: TEM|March 12, 2013
Autophagy: a targetable linchpin of cancer cell metabolismRobert D Leone, Ravi K Amaravadi
Nature Reviews. Cancer|July 8, 2020
Metabolism of immune cells in cancerRobert D Leone, Jonathan D Powell
Journal for Immunotherapy of Cancer|June 20, 2018
Targeting adenosine for cancer immunotherapyRobert D Leone, Leisha A Emens
Computational and Structural Biotechnology Journal|May 6, 2015
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapyRobert D Leone, Ying-Chun Lo, Jonathan D Powell
Cancer Cell|April 16, 2015
Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapyRobert D Leone, Maureen R Horton, Jonathan D Powell
Nature Reviews. Drug Discovery|August 1, 2019
Targeting metabolism to regulate immune responses in autoimmunity and cancerChirag H Patel, Robert D Leone, Maureen R Horton, et al.
Journal for Immunotherapy of Cancer|February 9, 2022
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapyRyan C Augustin, Robert D Leone, Aung Naing, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2018
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer modelsRobert D Leone, Im-Meng Sun, Min-Hee Oh, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against <i>Mycobacterium tuberculosis</i>Sadiya Parveen, Jessica Shen, Shichun Lun, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer Immunology Research|March 2, 2021
Fueling the Revolution: Targeting Metabolism to Enhance ImmunotherapyRobert D Leone, Jonathan D Powell
Trends in Endocrinology and Metabolism: TEM|March 12, 2013
Autophagy: a targetable linchpin of cancer cell metabolismRobert D Leone, Ravi K Amaravadi
Nature Reviews. Cancer|July 8, 2020
Metabolism of immune cells in cancerRobert D Leone, Jonathan D Powell
Journal for Immunotherapy of Cancer|June 20, 2018
Targeting adenosine for cancer immunotherapyRobert D Leone, Leisha A Emens
Computational and Structural Biotechnology Journal|May 6, 2015
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapyRobert D Leone, Ying-Chun Lo, Jonathan D Powell
Cancer Cell|April 16, 2015
Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapyRobert D Leone, Maureen R Horton, Jonathan D Powell
Nature Reviews. Drug Discovery|August 1, 2019
Targeting metabolism to regulate immune responses in autoimmunity and cancerChirag H Patel, Robert D Leone, Maureen R Horton, et al.
Journal for Immunotherapy of Cancer|February 9, 2022
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapyRyan C Augustin, Robert D Leone, Aung Naing, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2018
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer modelsRobert D Leone, Im-Meng Sun, Min-Hee Oh, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against <i>Mycobacterium tuberculosis</i>Sadiya Parveen, Jessica Shen, Shichun Lun, et al.
Pageof 3